Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?

Idiopathic pulmonary fibrosis (IPF) represents a chronic progressive fibrotic interstitial lung disease of unknown cause with an ominous prognosis. It remains an unprecedent clinical challenge due to its delayed diagnosis and unpredictable clinical course. The need for accurate diagnostic, prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomos, Ioannis, Roussis, Ioannis, Matthaiou, Andreas M., Dimakou, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604739/
https://www.ncbi.nlm.nih.gov/pubmed/37893169
http://dx.doi.org/10.3390/biomedicines11102796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604739/
https://www.ncbi.nlm.nih.gov/pubmed/37893169
http://dx.doi.org/10.3390/biomedicines11102796

Ejemplares similares